CNBX Pharmaceuticals Inc (CNBX)

Name: CNBX Pharmaceuticals Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$0.0

Net Income

-$114K

Operating Margin

N/A

Free Cash Flow

-$171K

Debt / Assets

13,639.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for CNBX Pharmaceuticals Inc (CNBX).
Income Statement (Quarterly)	2025-11-30	2025-02-28	2024-11-30	2024-08-31
Revenue	0	0	0	-17,570
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	64,000	64,743	36,837	126,468
Operating Expenses	64,000	64,743	36,837	52,533
Operating Income	-64,000	-64,743	-36,837	-52,533
Interest Expense	49,717	5,045	0	8,050
Income Before Tax	-113,719	-69,788	-34,352	-60,584
Income Tax Expense	0	0	0	0
Net Income	-113,719	-69,788	-34,352	-60,584
Per Share
EPS	0.00	0.00	0.00	0.02
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for CNBX Pharmaceuticals Inc (CNBX).
Income Statement (Annual)	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Revenue	0	130,074	410,165	29,958	0
Cost of Revenue	0	0	162,061	198,527	0
Gross Profit	0	130,074	410,165	-168,569	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	271,691	518,426	909,980	1,770,689	828,644
Operating Expenses	271,691	713,213	1,342,000	2,953,970	2,600,177
Operating Income	-271,691	-583,000	-931,000	-2,953,970	-2,600,177
Interest Expense	40,189	19,611	1,174	1,273	2,391
Income Before Tax	-313,976	-695,000	-3,710,000	-3,723,250	-3,194,447
Income Tax Expense	0	0	0	45,771	0
Net Income	-313,976	-695,000	-3,710,000	-3,769,021	-3,194,447
Per Share
EPS	0.00	-0.02	-0.42	-3.08	-0.02
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for CNBX Pharmaceuticals Inc (CNBX).
Balance Sheet (Quarterly)	2025-08-31	2024-08-31	2023-08-31	2022-08-31
Assets
Cash and Cash Equivalents	15,111	26,416	129,696	117,515
Short Term Investments	0	0	0	0
Net Receivables	3,326	4,967	0	80,772
Inventory	0	0	-94,612	-80,772
Total Current Assets	18,437	31,383	224,308	198,287
Property Plant Equipment	0	0	274,731	436,792
Goodwill and Intangibles	0	0	0	0
Total Assets	18,437	31,383	499,039	811,166
Liabilities
Account Payables	49,252	40,841	335,915	461,128
Short Term Debt	1,197,257	1,295,107	1,343,584	1,758,702
Total Current Liabilities	2,514,730	2,511,363	2,516,328	2,443,475
Long Term Debt	0	0	0	0
Total Liabilities	2,514,730	2,511,363	2,516,328	2,443,477
Shareholders Equity
Retained Earnings	-25,268,376	-24,954,400	-24,259,202	-20,548,968
Total Shareholders Equity	-2,496,293	-2,479,980	-2,017,289	-1,632,311

Balance sheet annual history for CNBX Pharmaceuticals Inc (CNBX).
Balance Sheet (Annual)	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Assets
Cash and Cash Equivalents	15,111	26,416	129,696	117,515	1,386,472
Short Term Investments	0	0	0	0	0
Net Receivables	3,326	4,967	0	80,772	0
Inventory	0	0	-94,612	-80,772	0
Total Current Assets	18,437	31,383	224,308	198,287	1,590,847
Property Plant Equipment	0	0	274,731	436,792	642,896
Goodwill and Intangibles	0	0	0	0	0
Total Assets	18,437	31,383	499,039	811,166	3,078,961
Liabilities
Account Payables	49,252	40,841	335,915	461,128	177,505
Short Term Debt	1,197,257	1,295,107	1,343,584	1,758,702	871,896
Total Current Liabilities	2,514,730	2,511,363	2,516,328	2,443,475	1,273,046
Long Term Debt	0	0	0	0	0
Total Liabilities	2,514,730	2,511,363	2,516,328	2,443,477	1,273,046
Shareholders Equity
Retained Earnings	-25,268,376	-24,954,400	-24,259,202	-20,548,968	-16,825,718
Total Shareholders Equity	-2,496,293	-2,479,980	-2,017,289	-1,632,311	1,805,915

Cash flow quarterly history for CNBX Pharmaceuticals Inc (CNBX).
Cash Flow Statement (Quarterly)	2025-08-31	2024-08-31	2023-08-31	2022-08-31
Operating Activities
Net Income	-313,976	-695,198	-3,710,234	-3,723,250
Depreciation & Amortization	0	72,320	162,061	198,527
Stock Based Compensation	0	139,720	180,480	728,869
Change in Working Capital	102,858	133,157	474,129	407,226
Operating Cash Flow	-171,305	-244,269	-112,521	-1,679,192
Investing Activities
Capital Expenditure	0	-1,196	1	-1,656
Investments	0	0	1	-1,656
Investing Cash Flow	0	113,477	24,702	25,229
Financing Activities
Debt Repayment	160,000	27,512	-100,000	-389,858
Common Stock Issued/Repurchased	0	0	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	160,000	27,512	100,000	389,858
Summary
Free Cash Flow	-171,305	-245,465	-112,520	-1,680,848
Net Change in Cash	-11,305	-103,280	12,181	-1,268,958

Cash flow annual history for CNBX Pharmaceuticals Inc (CNBX).
Cash Flow Statement (Annual)	2025-08-31	2024-08-31	2023-08-31	2022-08-31	2021-08-31
Operating Activities
Net Income	-313,976	-695,198	-3,710,234	-3,723,250	-3,194,447
Depreciation & Amortization	0	72,320	162,061	198,527	220,926
Stock Based Compensation	0	139,720	180,480	728,869	0
Change in Working Capital	102,858	133,157	474,129	407,226	-64,053
Operating Cash Flow	-171,305	-244,269	-112,521	-1,679,192	-2,492,913
Investing Activities
Capital Expenditure	0	-1,196	1	-1,656	-943
Investments	0	0	1	-1,656	-943
Investing Cash Flow	0	113,477	24,702	25,229	645,025
Financing Activities
Debt Repayment	160,000	27,512	-100,000	-389,858	0
Common Stock Issued/Repurchased	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	160,000	27,512	100,000	389,858	2,456,750
Summary
Free Cash Flow	-171,305	-245,465	-112,520	-1,680,848	-2,493,856
Net Change in Cash	-11,305	-103,280	12,181	-1,268,958	608,862